Abstract T cell exclusion restricts immune checkpoint blockade (ICB) efficacy for some hepatocellular carcinoma (HCC) patients. Epigenetic therapy provides new opportunities to rewire transcriptional programs. We have recently elucidated that pharmacological inhibition of histone deacetylase 8 (HDAC8) resulted in increased CD8 +T infiltration and enhanced ICB HCC. Moreover, this combined immuno...

Recent studies on molecular carcinogenesis suggest that the chemo-resistance of some cancers is largely due to presence of cancer stem cells (CSCs), which affect the chemotherapy outcome for hepatocellular carcinoma (HCC). However, currently no consensus on a CSC phenotype in HCC has been obtained. Here, we examined Sox12 as a novel CSC marker in HCC. Sox12+ versus Sox12- cells were purified fr...

BACKGROUND Liver cancer stem cells (LCSCs) have been shown to express higher levels of microRNA-21 (miR-21). Here, we examine the possible contributions of miR-21 to the phenotype of LCSCs in culture and in xenograft tumors in nude mice. METHODS The hepatocellular carcinoma cell line MHCC-97H was stably transformed with a retroviral vector to establish cells overexpressing miR-21, while a cel...

BACKGROUND & AIMS Acquisition of anoikis resistance is a prerequisite for metastasis in hepatocellular carcinoma (HCC). However, little is known about how energy metabolism and antioxidant systems are altered in anoikis-resistant (AR) HCC cells. We evaluated anti-tumor effects of a combination treatment of 3-bromopyruvate (3-BP) and buthionine sulfoximine (BSO) in AR HCC cells. METHODS We com...

Hepatocellular carcinoma (HCC) is the most prevalent primary liver malignancy worldwide and associated with a poor prognosis. Sophisticated molecular mechanisms biological characteristics need to be explored gain better understanding of HCC. The role metabolites in cancer immunometabolism has been widely recognized as hallmark tumor microenvironment (TME). Recent studies have focused on that ar...

RMP has been shown to function in the transcription regulation through association with RNA polymerase (RNAP) II subunit RPB5. It also has been shown to be required for the proliferation of hepatocellular carcinoma (HCC) cells with an antiapoptotic property. In this article, we further demonstrate that RMP displays distinct features in HCC cells compared with normal hepatic cells. RMP expressio...

Rate constants and activations parameters are reported for solvolyses of p-Z-substituted benzoyl chlorides (1, Z = OMe, Me, H, and Cl) in 97% w/w hexafluoroisopropanol-water (97H). Additional kinetic data are reported for solvolyses in acetic and formic acids. Plots of log k vs. σ(p) in 97H are consistent with previous research showing that a cationic reaction channel is dominant, even for solv...

Hepatocellular carcinoma (HCC) is a malignant tumor with high morbidity and mortality. At present, diagnostic methods such as imaging observation, serum testing tissue biopsy, well treatment surgical resection, radiotherapy, chemotherapy have certain limitations in clinical interventions for HCC due to the complex pathogenesis drug resistance of liver cancer, which seriously affect survival pro...

Hepatocellular carcinoma (HCC) is considered a classic inflammation-associated tumor that usually originates from chronic hepatitis, where an intense and inflammatory response leads to the accumulation of mutations eventually carcinogenesis under conditions persistent liver injury. In recent years, immunotherapy for HCC has continued evolve, as naturally filled with large variety immune cells, ...

HCC is marked by genetic heterogeneity and activated hepatic stellate cells (HSC) are considered key players during development. The paracrine effect of different cell lines on the activation primary hHSC was accompanied differential AMPK depending line used. Pharmacological treatment inhibited HCC-induced through AMPK-dependent AMPK-independent mechanisms. This heterogenic confirmed data minin...